Search

Heron Therapeutics Inc

Lezárt

SzektorEgészségügy

0.34 -2.86

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

0.34

Maximum

0.4

Fő mutatók

By Trading Economics

Bevétel

2.6M

-5.5M

Értékesítés

3M

38M

Egy részvényre jutó nyereség

-0.03

Profit margin

-14.573

Munkavállalók

128

EBITDA

2.1M

-5.5M

Osztalékok

By Acuity

Következő eredményjelentés

2026. nov. 3.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

-41M

55M

Előző nyitás

3.2

Előző zárás

0.34

Hangulat hírek alapján

By Acuity

30%

70%

38 / 340 Rangsor szerint Healthcare

Heron Therapeutics Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. okt. 2. 23:35 UTC

News

Honeywell International Inc. is seeing slight gains in after-market trading, following commentary from its CTO on AI implementation challenges in industrial settings.

2026. okt. 2. 23:35 UTC

News

Deere & Co. is trading higher in after-market hours, driven by growth in construction and small equipment units despite weaker results in agriculture.

2026. okt. 2. 23:25 UTC

News

Kohl's Corp has a market valuation of approximately $2.1 billion, with after-market trading showing modest gains near the upper end of its one-month range.

2026. okt. 2. 23:11 UTC

News

Intellia Therapeutics Inc granted inducement awards of 44.45k restricted stock units to new employees, with the stock trading lower in after-market hours.

2026. okt. 2. 23:10 UTC

News

McDonald's Corp is seeing a slight increase in after-market trading, supported by its McDonald's NEXT initiative to enhance revenue through customer engagement.

2026. okt. 2. 23:05 UTC

News

Boeing's stock rose slightly in after-market trading after the FAA confirmed a software glitch in the 737 MAX does not pose an in-flight safety issue.

2026. okt. 2. 23:05 UTC

News

American Airlines Group Inc. experienced routine after-market trading, remaining roughly flat since Friday's close amid a recent downward trend over the last three sessions.

2026. okt. 2. 23:05 UTC

News

Verra Mobility Corp is higher in after-market trading, rebounding from recent declines amid investor concerns over the upcoming leadership transition effective November 1, 2026.

2026. okt. 2. 23:01 UTC

Social Media
News

In after-market hours, Synaptics shares are trading lower as Onsemi revises its acquisition proposal to $123 per share in cash, valuing the deal at $5.7 billion.

2026. okt. 2. 23:01 UTC

News
Social Media

GameStop shares rise in after-hours trading following CEO Ryan Cohen's purchase of 700k Class A shares for approximately $17 million, signaling confidence in the company's prospects.

2026. okt. 2. 23:01 UTC

Social Media
News

Vistra Corp shares are higher in after-market trading as the U.S. Department of Energy plans to extend $4 billion in loans for nuclear reactor upgrades.

2026. okt. 2. 21:03 UTC

Macro Event
News

USD/THB exchange rate is declining modestly, influenced by disappointing U.S. employment data, including a lower-than-expected jobs added figure of 46k in September.

2026. okt. 2. 21:01 UTC

News

Xenon Pharmaceuticals Inc announced equity inducement grants to new employees, with after-market trading showing a slight gain since Friday's close.

2026. okt. 2. 20:12 UTC

News

Endava PLC's stock is declining in after-market trading amid increased scrutiny and a class action lawsuit following CFO Mark Thurston's administrative leave due to accounting concerns.

2026. okt. 2. 20:09 UTC

News

Cloudflare Inc shares are declining, pulling back after earlier strength, amid broader market weakness, following a modest drop since Thursday's close.

2026. okt. 2. 20:09 UTC

News
Social Media

Rocket Lab shares are advancing following ARK Invest's $16.4 million purchase of 233.48k shares, adding to over $44 million in recent investments.

2026. okt. 2. 20:09 UTC

News
Social Media

Oracle Corp shares are advancing following a $3.48 million insider purchase by Board Member Stephen Rusckowski and a 29.61% revenue growth rate.

2026. okt. 2. 20:09 UTC

Macro Event
News
Social Media

MARA Holdings Inc. sees bullish option activity with call volume at 68.48k contracts, three times the expected amount, as shares move higher.

2026. okt. 2. 20:09 UTC

Correlated Moves
News
Macro Event

Ford Motor Co trades lower since Thursday's close.

2026. okt. 2. 20:09 UTC

Correlated Moves
News
Macro Event
Social Media

Dell Technologies partners with Jera for a $15 billion data center near Tokyo, contributing to Japan's $140 billion investment in data center development.

2026. okt. 2. 20:09 UTC

News
Macro Event

Marvell Technology Inc shares are up as positive sentiment builds ahead of its October 6 Investor Day, with calls outpacing puts in options trading.

2026. okt. 2. 20:09 UTC

Macro Event
News

Booking Holdings Inc. shares fell sharply as mixed macroeconomic indicators, including disappointing U.S. employment data, weighed on market sentiment.

2026. okt. 2. 20:09 UTC

News

Scotiabank upgraded Americold Realty Trust to Sector Outperform, maintaining a $16 price target, contributing to gains in today's trading session.

2026. okt. 2. 20:09 UTC

News
Social Media

Shares of AppLovin fell sharply after a court denied its request for a restraining order against Unity's Ad Quality SDK, indicating competitive pressure.

2026. okt. 2. 20:09 UTC

News

Home Depot has paused its buyback program, focusing on debt reduction and a nationwide Express Delivery rollout set for August 2026, while shares are higher today.

2026. okt. 2. 20:09 UTC

News

C3.ai Inc shares fell as Citizens maintained its Market Perform rating amid ongoing developments in the artificial intelligence sector, despite earlier gains in the session.

2026. okt. 2. 20:09 UTC

News
Social Media

Broadcom is pursuing $60 billion in financing to support AI chip buyers, including a $42 billion senior-secured tranche, as shares advance despite earlier pullbacks.

2026. okt. 2. 20:09 UTC

Social Media
News

Arm Holdings PLC shares advanced, supported by easing supply constraints for its AGI CPU chip and an Overweight rating from Piper Sandler.

2026. okt. 2. 20:09 UTC

Social Media
News

Oppenheimer raised its price target on Semtech Corp to $225, citing strong AI data center demand, as the stock remains higher since Thursday's close.

2026. okt. 2. 20:07 UTC

News

Doximity Inc faces a class action lawsuit alleging false statements about revenue drivers, contributing to the stock's decline despite earlier gains in the session.

Társak összehasonlítása

Árváltozás

Heron Therapeutics Inc Előrejelzés

Értékelési konszenzus

By TipRanks

Semleges

2 ratings

0

Vétel

2

Tartás

0

Eladás

Hangulat

By Acuity

38 / 340 Rangsor szerint Egészségügy

Hangulat hírek alapján

Bullish bizonyíték

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag feletti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Heron Therapeutics Inc

Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Cary, North Carolina.